Methusalem Podcast

Methusalem Podcast with Niklas Anzinger

41 min · 23. feb. 2026
episode Methusalem Podcast with Niklas Anzinger cover

Beskrivelse

In this episode of the Methusalem Podcast, I discuss with Niklas Anzinger, founder and CEO of Infinita City, the story behind Próspera, a special economic zone on the island of Roatán, Honduras. Niklas shares his journey from public policy and the Berlin startup scene to building a jurisdiction designed to accelerate biotech and longevity innovation. We cover how Próspera operates as a startup city with its own regulatory framework, why Niklas believes FDA-style regulatory monopolies are the biggest bottleneck in longevity research rather than the science itself, and how Próspera's insurance-based regulatory model offers a market-driven alternative. We also discuss biotech companies already operating on-site. If you're a founder or researcher interested in launching a biotech company in this unique regulatory environment, check out the BioHub Startup Accelerator at luma.com/BioHub2026 [https://luma.com/BioHub2026]. For more information on Infinita City and everything happening at Prospera, visit the homepage at infinita.city [https://www.infinita.city/].

Kommentarer

0

Vær den første til at kommentere

Tilmeld dig nu og bliv en del af Methusalem Podcast-fællesskabet!

Kom i gang

2 måneder kun 19 kr.

Derefter 99 kr. / måned · Opsig når som helst.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

Alle episoder

5 episoder

episode Methusalem Podcast with Niklas Anzinger cover

Methusalem Podcast with Niklas Anzinger

In this episode of the Methusalem Podcast, I discuss with Niklas Anzinger, founder and CEO of Infinita City, the story behind Próspera, a special economic zone on the island of Roatán, Honduras. Niklas shares his journey from public policy and the Berlin startup scene to building a jurisdiction designed to accelerate biotech and longevity innovation. We cover how Próspera operates as a startup city with its own regulatory framework, why Niklas believes FDA-style regulatory monopolies are the biggest bottleneck in longevity research rather than the science itself, and how Próspera's insurance-based regulatory model offers a market-driven alternative. We also discuss biotech companies already operating on-site. If you're a founder or researcher interested in launching a biotech company in this unique regulatory environment, check out the BioHub Startup Accelerator at luma.com/BioHub2026 [https://luma.com/BioHub2026]. For more information on Infinita City and everything happening at Prospera, visit the homepage at infinita.city [https://www.infinita.city/].

23. feb. 202641 min